Soleno Therapeutics (SLNO) had the highest return between July 28, 2023 and August 1, 2024 by a mid-cap US stock, returning 927.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 7/28/2023 - 8/1/2024 | 927.14% |
Ast Spacemobile (ASTS) | 7/28/2023 - 8/1/2024 | 417.47% |
Avidity Biosciences (RNA) | 7/28/2023 - 8/1/2024 | 383.41% |
Longboard Pharmaceuticals (LBPH) | 7/28/2023 - 8/1/2024 | 375.72% |
GeneDx (WGS) | 7/28/2023 - 8/1/2024 | 341.78% |
Viking Therapeutics (VKTX) | 7/28/2023 - 8/1/2024 | 294.87% |
Dyne Therapeutics (DYN) | 7/28/2023 - 8/1/2024 | 289.63% |
Abercrombie & Fitch (ANF) | 7/28/2023 - 8/1/2024 | 263.49% |
Sezzle Inc Common Stock (SEZL) | 7/28/2023 - 8/1/2024 | 240.04% |
Janux Therapeutics (JANX) | 7/28/2023 - 8/1/2024 | 228.01% |
Modine Manufacturing (MOD) | 7/28/2023 - 8/1/2024 | 212.9% |
ADMA Biologics (ADMA) | 7/28/2023 - 8/1/2024 | 212.63% |
United States Cellular (USM) | 7/28/2023 - 8/1/2024 | 206.27% |
Rush Street Interactive (RSI) | 7/28/2023 - 8/1/2024 | 197.51% |
Crinetics Pharmaceuticals (CRNX) | 7/28/2023 - 8/1/2024 | 180.1% |
Telephone and Data Systems (TDS) | 7/28/2023 - 8/1/2024 | 173.79% |
Jackson Financial (JXN) | 7/28/2023 - 8/1/2024 | 171.77% |
Zeta Global (ZETA) | 7/28/2023 - 8/1/2024 | 170.46% |
Powell Industries (POWL) | 7/28/2023 - 8/1/2024 | 166.72% |
Rhythm Pharmaceuticals (RYTM) | 7/28/2023 - 8/1/2024 | 162.85% |
Nextnav Acquisition (NN) | 7/28/2023 - 8/1/2024 | 161.54% |
Hawkins (HWKN) | 7/28/2023 - 8/1/2024 | 160.72% |
IES (IESC) | 7/28/2023 - 8/1/2024 | 157.01% |
CleanSpark (CLSK) | 7/28/2023 - 8/1/2024 | 154.9% |
Edgewise Therapeutics (EWTX) | 7/28/2023 - 8/1/2024 | 150.37% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
